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Table 1 Plastic surgeon reported closure of abdominal secondary defect (n = 83) 
Phase of closure Product  N (%) 
Rectus sheath mesh 
No mesh used 
Mesh (type not reported) 
Prolene mesh 
Ultrapro 
Vipro 
Parietax 
Vicryl 
Missing 
27 (34) 
15 (18) 
4 (5) 
3 (4) 
2 (2) 
1 (1) 
1 (1) 
30 (36) 
Closure of rectus sheath 
Nylon 
Polydiaxanone 
Barbed suture 
Vicryl 
Ethibond 
Prolene 
Missing 
37 (45) 
6 (7) 
4 (5) 
2 (2) 
1 (1) 
1 (1) 
32 (39) 
Closure of Scarpa’s fascia 
Polydiaxanone 
Vicryl 
Monocryl 
Barbed suture 
Vicryl 
Missing 
23 (28) 
14 (17) 
8 (10) 
6 (7) 
2 (2) 
21 (25) 
Deep dermal closure 
Monocryl 
Vicryl 
Barbed suture 
Polydiaxanone 
Insorb 
Missing 
34 (41) 
10 (12) 
7 (8) 
3 (4) 
3 (4) 
26 (31) 
Skin closure 
Monocryl 
Polydiaxanone 
Barbed suture 
Vicryl 
46 (55) 
3 (4) 
2 (2) 
1 (1) 
Staples 
Missing 
1 (1) 
30 (36) 
Wound dressing 
Tissue glue 
Steristrips 
Tissue glue and dressing 
Prineo 
Missing 
9 (11) 
8 (10) 
7 (8) 
4 (5) 
55 (66) 
Data derived from free text responses.  Missing data documented where no reference to that part of closure was 
mentioned in the response. 
  
Table 2 Anaesthetists reported preferences for postoperative analgesia (n/N%). Multiple responses allowed. 
Analgesic Regular PRN No Missing 
Paracetamol 67 (94) 0 (0) 2 (3) 3 (3) 
Patient controlled analgesia 40 (56) 10 (14) 19 (27) 3 (3) 
NSAID (e.g. ibuprofen) 34 (48) 7 (10) 28 (39) 3 (3) 
Oral morphine 16 (23) 25 (35) 28 (39) 3 (3) 
Gabapentin 13 (18) 2 (3) 54 (76) 3 (3) 
Compound analgesic (e.g. co-codamol) 5 (7) 7 (10) 57 (80) 3 (3) 
Aspirin 1 (1) 0 (0) 68 (96) 3 (3) 
COX-2 Inhibitor (e.g. Celecoxib) 1 (1) 0 (0) 68 (96) 3 (3) 
NSAID, non-steroidal anti-inflammatory drug; COX, cyclooxygenase  
  
Table 3 Comparison of optiFLAPP responses with ERAS protocol and ABS/BAPRAS guidance 
Item ERAS Society Recommendation ABS / BAPRAS Recommendations optiFLAPP experience 
Preadmission 
information, 
education, and 
counseling   
Patients should receive detailed 
preoperative counseling. 
Patients should receive information 
in a format and level of detail that 
meets their individual needs. 
In addition to clinic consultation, 
paper-based information widely 
used but limited use of electronic 
resources. 
Preadmission 
optimization   
For daily smokers, 1 month of 
abstinence before surgery is 
beneficial.  
For patients who are obese, weight 
reduction to achieve a BMI ≤30 
kg/m2 before surgery is beneficial. 
For alcohol abusers, 1 month of 
abstinence before surgery is 
beneficial. For appropriate groups, 
referral should be made to 
resources for these behavior 
changes. 
All women should undergo a pre-
operative assessment process prior 
to admission. 
All patients attend a preadmission 
clinic to prepare them for surgery. 
BMI and smoking not examined by 
survey. 
Perforator flap 
planning  
If preoperative perforator mapping 
is required, CTA is recommended. 
No specific guidance. Preoperative imaging is performed 
in 92% patients (CTA 67%) 
Perioperative 
fasting  
Preoperative fasting should be 
minimized and patients should be 
allowed to drink clear fluids up to 2 
hour before surgery. 
No specific guidance. Most patients are encouraged to 
drink up to 2 hours before surgery. 
Preoperative 
carbohydrate 
loading  
Preoperative maltodextrin-based 
drinks should be given to patients 2 
hour before surgery. 
No specific guidance. Only 13% given a specific oral fluid 
prescription for carbohydrate 
loading. 
Venous 
thromboembolism 
prophylaxis   
Patients should be assessed for 
venous thromboembolism risk. 
Unless contraindicated, and 
balanced by the risk of bleeding, 
patients at a higher risk should 
LMWH according to risk factors 12 
hours prior to surgery (night before 
operation). TEDS on admission. 
Leave flowtrons on for first 24 
hours post operation. Encourage 
Most patients receive combined 
VTE prophylaxis of LMWH and 
TEDS. Few continue VTE 
prophylaxis beyond the admission. 
receive low-molecular-weight 
heparin or unfractionated heparin 
until ambulatory or discharged. 
Mechanical methods should be 
added. 
ankle dorsi / plantar flexion after 
flowtrons removed. 
No guidelines for tamoxifen 
 
 
Most surgeons stop tamoxifen 
Antimicrobial 
prophylaxis   
Chlorhexidine skin preparation 
should be performed and 
intravenous antibiotics covering 
common skin organisms should be 
given within 1 hour of incision. 
2% chlorhexidine with 70% 
isopropyl alcohol with tint provides 
the best skin decontamination. A 
single intravenous dose of 
prophylactic antibiotic given on 
induction of anaesthesia. If the 
operation lasts longer than 4 hours 
or there is significant blood loss, a 
second dose may be indicated. 
All patients receive induction 
antibiotics. 45% receive antibiotics 
beyond the procedure. 
Postoperative 
nausea and 
vomiting 
prophylaxis  
Women should receive preoperative 
and intraoperative medications to 
mitigate postoperative nausea and 
vomiting. 
Propofol infusions, 5HT3 
antagonists and a multimodal 
approach to minimize retching. 
Not assessed. 
Preoperative and 
intraoperative 
analgesia  
Women should receive multimodal 
analgesia to mitigate pain. 
No specific guidance. 30% anaesthetists report 
prescribing preoperative analgesia 
Standard 
anesthetic 
protocol 
General anesthesia with TIVA is 
recommended. 
No specific guidance. 39% anaesthetists use TIVA; 37% 
use volatile anesthesia 
Preventing 
intraoperative 
hypothermia   
Preoperative and intraoperative 
measures, such as forced air, to 
prevent hypothermia should be 
instituted. Temperature monitoring 
is required to ensure the patient’s 
body temperature is maintained 
above 36°C. 
Patient temperature should be 
carefully monitored. No specific 
guidance on warming. 
A range of measures were reported 
to prevent hypothermia. Large 
variation in preoperative warming 
and forced air warming devices. 
Perioperative 
intravenous fluid 
management   
Over resuscitation or under 
resuscitation of fluids should be 
avoided and water and electrolyte 
balance should be maintained. Goal-
directed therapy is a useful method 
of achieving these goals.  
Balanced crystalloid solutions, 
rather than saline, is recommended.  
Vasopressors are recommended to 
support fluid management and do 
not negatively affect free flaps. 
Fluid balance must be carefully 
monitored and patients kept 
adequately hydrated. 
Goal directed therapy not widely 
used.  
 
 
Hartmann’s solution was the 
preferred solution for maintenance 
and fluid boluses. 
84% anaesthetists reported always 
or sometimes using vasopressors. 
Postoperative 
analgesia   
Multimodal postoperative pain 
management regimens are opioid-
sparing and should be used. 
A multi-modal approach to 
analgesia should be considered – 
options include patient controlled 
analgesia, regional techniques, local 
anesthetic wound infiltration and a 
combination of opioid and non-
opioid analgesics. 
Opioid patient controlled analgesia 
widely used. Low use of NSAIDs. 
Approximately half of clinicians 
used regional blocks. 
Early feeding Patients should be encouraged to 
take fluids and food orally as soon 
as possible, preferably within 24 
hour after surgery. 
No specific guidance. Not assessed. 
Postoperative flap 
monitoring 
Flap monitoring within the first 72 
hour should occur frequently. 
Clinical evaluation is sufficient for 
monitoring, with implantable 
Doppler devices recommended in 
cases of buried flaps. 
Monitor flap every 30 minutes for 
24 hours and hourly thereafter. 
Range of flap monitoring protocols. 
Generally continue for 3 days and 
surface Doppler used as an adjunct. 
Postoperative 
wound 
management 
For incisional closure, conventional 
sutures are recommended. Complex 
wounds following skin necrosis are 
treatable with débridement and 
negative-pressure wound therapy. 
No specific guidance other than 
patients should be monitored for 
complications.  
Large variation in abdominal 
wound closure techniques including 
the use of barbed sutures and 
closure devices. 
Early mobilization Patients should be mobilized within 
the first 24 hours after surgery. 
No specific guidance. Not assessed. 
Post discharge 
home support and 
physiotherapy 
Early physiotherapy, supervised 
exercise programs, and other 
supportive care initiatives should be 
instituted after 
Patients should have early access to 
specialist physiotherapy. 
Not assessed. 
Patient 
satisfaction 
No specific guidance. Patients’ satisfaction with breast 
reconstruction outcome should be 
measured using standardized 
assessment tools. 
Only 30% surgeons report 
collecting patient reported 
outcomes 
CTA, computed tomography angiography; VTE, venous thromboembolism; LMWH, low molecular weight heparin; 
TEDS, thromboembolic deterrent stockings; ERAS, enhanced recovery after surgery; ABS, Association of Breast 
Surgeons; BAPRAS, British Association of Plastic, Reconstructive and Aesthetic Surgeons; TIVA, total intravenous 
anesthesia 
